224 related articles for article (PubMed ID: 6282911)
1. Inhibition of neoplastic cell growth by quiescent cells is mediated by serum concentration and cAMP phosphodiesterase inhibitors.
Bertram JS; Bertram BB; Janik P
J Cell Biochem; 1982; 18(4):515-38. PubMed ID: 6282911
[No Abstract] [Full Text] [Related]
2. Differential inhibition of cyclic AMP and cyclic GMP hydrolysis in rat renal cortex.
Zenser TV; Craven PA; DeRubertis FR; Davis BB
Arch Biochem Biophys; 1977 Jan; 178(2):598-606. PubMed ID: 189700
[No Abstract] [Full Text] [Related]
3. Phosphodiesterases in vascular endothelial cells.
Kishi Y; Ashikaga T; Numano F
Adv Second Messenger Phosphoprotein Res; 1992; 25():201-13. PubMed ID: 1372811
[No Abstract] [Full Text] [Related]
4. Properties of acidic saccharides produced by B16 melanoma cells treated with 1-methyl-3-isobutylxanthine.
Banks J; Kreider JW; Sato C; Davidson EA
Cancer Res; 1975 Sep; 35(9):2383-9. PubMed ID: 167957
[TBL] [Abstract][Full Text] [Related]
5. Requirements for and kinetics of growth arrest of neoplastic cells by confluent 10T1/2 fibroblasts induced by a specific inhibitor of cyclic adenosine 3':5'-phosphodiesterase.
Bertram JS; Faletto MB
Cancer Res; 1985 May; 45(5):1946-52. PubMed ID: 2985240
[TBL] [Abstract][Full Text] [Related]
6. 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
Drees M; Zimmermann R; Eisenbrand G
Cancer Res; 1993 Jul; 53(13):3058-61. PubMed ID: 8391385
[TBL] [Abstract][Full Text] [Related]
7. [Outer retinal rod segment cyclic nucleotide phosphodiesterase; protein inhibitor separation, bimodal effect of GTP].
Dumler IL; Furaev VV; Etingof RN
Dokl Akad Nauk SSSR; 1980; 253(6):1504-8. PubMed ID: 6253254
[No Abstract] [Full Text] [Related]
8. [Inhibition of cyclic nucleotide phosphodiesterase from the rod outer segments of the frog retina by 3-hydroxypyridine].
Polianskiĭ NB; Smirnov LD; Shvedova AA; Kagan VE
Nauchnye Doki Vyss Shkoly Biol Nauki; 1984; (1):27-31. PubMed ID: 6199045
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G
Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161
[TBL] [Abstract][Full Text] [Related]
10. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
Zhou L; Thompson WJ; Potter DE
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
[TBL] [Abstract][Full Text] [Related]
11. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
Miyamoto M; Takayanagi I; Ohkubo H; Takagi K
Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
[No Abstract] [Full Text] [Related]
12. Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors.
Lagente V; Hichami A; Boichot E; Martins MA; Silva PM
Allerg Immunol (Paris); 1995 Feb; 27(2):34-9. PubMed ID: 7710653
[TBL] [Abstract][Full Text] [Related]
13. Separation of multiple forms of cyclic nucleotide phosphodiesterase from hog heart.
Nasu S
Bull Osaka Med Sch; 1976 Oct; 22(2):51-68. PubMed ID: 203355
[No Abstract] [Full Text] [Related]
14. Xanthines and skeletal muscle: lack of relationship between phosphodiesterase inhibition and increased twitch tension in rat diaphragms.
Kramer GL; Wells JN
Mol Pharmacol; 1980 Jan; 17(1):73-8. PubMed ID: 6247639
[No Abstract] [Full Text] [Related]
15. Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: evaluation of structure-activity relationships.
Wu PH; Phillis JW; Nye MJ
Life Sci; 1982 Dec; 31(25):2857-67. PubMed ID: 6298531
[No Abstract] [Full Text] [Related]
16. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones.
Goff AK; Major PW
FEBS Lett; 1976 Jan; 61(2):144-7. PubMed ID: 174943
[No Abstract] [Full Text] [Related]
17. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
[TBL] [Abstract][Full Text] [Related]
19. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
Miot F; Erneux C; Wells JN; Dumont JE
Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
[TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
Rybalkin SD; Bornfeldt KE
Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
